JAK Mutations as Escape Mechanisms to Anti-PD-1 Therapy
- PMID: 28167612
- DOI: 10.1158/2159-8290.CD-16-1439
JAK Mutations as Escape Mechanisms to Anti-PD-1 Therapy
Abstract
JAK mutations could be one of the primary escape mechanisms to anti-PD-1/PD-L1 immunotherapy via impaired IFNγ signaling in cancer cells and could be used to identify patients unlikely to benefit from these treatments. Cancer Discov; 7(2); 128-30. ©2017 AACR.See related article by Shin et al., p. 188.
©2017 American Association for Cancer Research.
Comment on
-
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.Cancer Discov. 2017 Feb;7(2):188-201. doi: 10.1158/2159-8290.CD-16-1223. Epub 2016 Nov 30. Cancer Discov. 2017. PMID: 27903500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
